Switch to
More onapp

How to use scorecard? Learn more

Zenotech Laboratories Ltd

ZENOTECH
Health CareBiotechnology
SmallcapWith a market cap of ₹474 cr, stock is ranked 1,854
High RiskStock is 3.36x as volatile as Nifty
78.600.87 (+1.12%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareBiotechnology
SmallcapWith a market cap of ₹474 cr, stock is ranked 1,854
High RiskStock is 3.36x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
71.23
PB RatioPB Ratio
5.24
Dividend YieldDiv. Yield
Sector PESector PE
49.79
Sector PBSector PB
6.29
Sector Div YldSctr Div Yld
0.52%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves therapy areas, such as oncology and anesthesiology.

Financial TrendFinancial statements 

202120222023202422.8637.2043.5041.83-1.2122.1811.588.29
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnOct 24, 2024

ZENOTECH LABORATORIES LTD. - 532039 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

ZENOTECH LABORATORIES LTD. - 532039 - Announcement under Regulation 30 (LODR)-Newspaper Publication | Download

Board Meeting 
Announced OnOct 23, 2024

ZENOTECH LABORATORIES LTD. - 532039 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 And Appointment Of Dr. Sachin Laxmanappa Gavandare As Chief Executive Officer (Key Managerial Personnel) Of The Company With Immediate Effect. | Download

ZENOTECH LABORATORIES LTD. - 532039 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 And Appointment Of Dr. Sachin Laxmanappa Gavandare As Chief Executive Officer (Key Managerial Personnel) Of The Company With Immediate Effect. | Download

Result 
Announced OnOct 23, 2024

ZENOTECH LABORATORIES LTD. - 532039 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

ZENOTECH LABORATORIES LTD. - 532039 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 | Download

See all events